About PANTHERx Rare
PANTHERx Rare is a Healthcare company based in Pittsburgh (United States) founded in 2011, and was acquired by Warburg Pincus in June 2026. Provider of medical treatment plans, data analytics, call center, and other services. PANTHERx Rare has raised $200 thousand across 1 funding round from investors including Centene, General Atlantic and Warburg Pincus. Its website pantherxrare.com draws about 26 thousand monthly visits. PANTHERx Rare offers products and services including RxARECARE, Medication Delivery, and Clinical Programs. Its focus areas include Services for Healthcare Providers, BPO and Diversified. Its legal entity is PANTHERx Specialty LLC. Its competitors include Centivo, MultiPlan and Omega Healthcare; 1 of its 3 listed competitors has raised funding.
Company details
PANTHERx Rare was founded in 2011 in Pittsburgh, United States, within the healthcare sector focused on rare diseases. Specialty pharmacy operations are conducted, including the development of medical treatment plans, data analytics for patient outcomes, and call center support for access and adherence. Additional services such as reimbursement assistance and patient navigation are handled across the United States to facilitate therapy management.
- Headquarters Pittsburgh, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pantherxrare.com
- Social LinkedIn X Facebook
- Acquired by Centene (Dec 2020)
- Legal Name Pantherx Specialty Llc
- Total Equity Funding$200K (USD)
in 1 rounds
- Latest Funding Round$200K (USD), Seed
Feb 2018
- InvestorsCentene
& 4 more
- Acquired by
Products & Services of PANTHERx Rare
PANTHERx Rare offers a comprehensive portfolio of products and services, including RxARECARE, Medication Delivery, and Clinical Programs.
Offers compassionate care and access to rare medications for patients.
Streamlines access to rare disease treatments for various stakeholders.
Optimizes outcomes for rare conditions through expert support services.
Funding Insights of PANTHERx Rare
PANTHERx Rare has successfully raised a total of $200K through 1 strategic funding round. The most recent funding activity was a Seed round of $200 thousand completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $200,000
- Total Rounds 1
- Last Round Seed — $200,000
- First Round $200,000
(Feb 2018)
All 1 funding rounds of PANTHERx Rare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2018 | $200,000 | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in PANTHERx Rare
PANTHERx Rare has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Centene, General Atlantic and Warburg Pincus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Nautic Partners is engaged in middle market private equity investments. | 1986 | nautic.com | Providence, United States | |
Private equity fund focused on global markets | 1980 | generalatlantic.com | New York, United States | |
A private investment firm focused on essential industries is operated. | 2013 | vistria.com | Chicago, United States | |
Multi-stage private equity investments are pursued across diverse sectors. | 1966 | warburgpincus.com | New York, United States | |
Contracting, Network Development, Managed Care and Health insurance solutions company | 1984 | centene.com | St. Louis, United States |
Investor details for PANTHERx Rare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PANTHERx Rare
2 people are tracked at PANTHERx Rare (2 in team).
| Name | Role | Group |
|---|---|---|
Robert Snyder | Executive Chair | Team |
Molly Staver | Controller | Team |
Complete people profiles for PANTHERx Rare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PANTHERx Rare
5 dated milestones of PANTHERx Rare across 15 years, from founding to its latest funding, stage changes and deals.
- Founded PANTHERx Rare is founded.
- Funding First funding round of $200K.
- Exit Acquired by Centene.
- Exit Acquired by Vistria.
- Exit Acquired by Warburg Pincus.
Competitors of PANTHERx Rare
PANTHERx Rare has 3 listed competitors in our database, 1 of them funded. They include Centivo, MultiPlan and Omega Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| centivo.com | 2017 | New York, United States | $224M | 212 | Provider of self funded health plan | |
| multiplan.us | 1980 | New York, United States | 2,800 | Medical payment integrity and analytics services are provided by MultiPlan. | ||
| omegahms.com | 2003 | Boca Raton, United States | 26,750 | Healthcare outsourcing services are provided to various sectors. |
Detailed competitors of PANTHERx Rare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PANTHERx Rare
The website of PANTHERx Rare (pantherxrare.com) receives about 26.5K visits a month.
- Monthly visits26.5K
▲ 40.9% vs previous month
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as PANTHERx Rare (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pantherx Rare
Complete news archive for PANTHERx Rare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PANTHERx Rare
PANTHERx Rare was founded in 2011 and raised its 1st funding round 7 years after it was founded.
PANTHERx Rare is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
PANTHERx Rare is a funded company, having raised a total of $200K across 1 funding round to date. The company's 1st funding round was a Seed of $200K, raised on Feb 2018.
PANTHERx Rare was founded in 2011 in Pittsburgh, United States, within the healthcare sector focused on rare diseases. Specialty pharmacy operations are conducted, including the development of medical treatment plans, data analytics for patient outcomes, and call center support for access and adherence. Additional services such as reimbursement assistance and patient navigation are handled across the United States to facilitate therapy management.
PANTHERx Rare's top competitors include Centivo, MultiPlan and Omega Healthcare.
PANTHERx Rare offers RxARECARE, Medication Delivery, and Clinical Programs.
PANTHERx Rare has 5 investors. Key investors include Centene, General Atlantic, Warburg Pincus, Nautic Partners, and The Vistria Group.
PANTHERx Rare operates through Pantherx Specialty Llc.
Yes. PANTHERx Rare was acquired by Centene in December 2020.